Literature DB >> 21658635

European cystic fibrosis bone mineralisation guidelines.

Isabelle Sermet-Gaudelus1, Maria Luisa Bianchi, Michèle Garabédian, Robert M Aris, Alison Morton, Dana S Hardin, Sarah L Elkin, Juliet E Compston, Steven P Conway, Mireille Castanet, Susan Wolfe, Charles S Haworth.   

Abstract

Patients with cystic fibrosis (CF) are at risk of developing low bone mineral density (BMD) and fragility fractures. This paper presents consensus statements that summarise current knowledge of the epidemiology and pathophysiology of CF-related skeletal deficits and provides guidance on its assessment, prevention and treatment. The statements were validated using a modified Delphi methodology.
Copyright © 2011 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21658635     DOI: 10.1016/S1569-1993(11)60004-0

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  31 in total

1.  Body composition and lung function in children with cystic fibrosis and meconium ileus.

Authors:  Artemis Doulgeraki; Argyri Petrocheilou; Glykeria Petrocheilou; George Chrousos; Stavros-Eleftherios Doudounakis; Athanasios G Kaditis
Journal:  Eur J Pediatr       Date:  2017-04-13       Impact factor: 3.183

2.  Reduced bone volumetric density and weak correlation between infection and bone markers in cystic fibrosis adult patients.

Authors:  D Gensburger; S Boutroy; R Chapurlat; R Nove-Josserand; S Roche; M Rabilloud; I Durieu
Journal:  Osteoporos Int       Date:  2016-05-11       Impact factor: 4.507

3.  Vitamin D treatment modulates immune activation in cystic fibrosis.

Authors:  T Pincikova; D Paquin-Proulx; J K Sandberg; M Flodström-Tullberg; L Hjelte
Journal:  Clin Exp Immunol       Date:  2017-05-24       Impact factor: 4.330

Review 4.  Update on Bone Health in Pediatric Chronic Disease.

Authors:  Kristen M Williams
Journal:  Endocrinol Metab Clin North Am       Date:  2016-04-07       Impact factor: 4.741

5.  Intermachine differences in DXA measurements vary by skeletal site, and impact the assessment of low bone density in children.

Authors:  Babette S Zemel; Halley Wasserman; Andrea Kelly; Bo Fan; John Shepherd; Joan Lappe; Vicente Gilsanz; Sharon Oberfield; Karen K Winer; Heidi J Kalkwarf
Journal:  Bone       Date:  2020-08-11       Impact factor: 4.398

Review 6.  Bone disease in cystic fibrosis: new pathogenic insights opening novel therapies.

Authors:  J Jacquot; M Delion; S Gangloff; J Braux; F Velard
Journal:  Osteoporos Int       Date:  2015-10-02       Impact factor: 4.507

Review 7.  Cystic fibrosis: a clinical view.

Authors:  Carlo Castellani; Baroukh M Assael
Journal:  Cell Mol Life Sci       Date:  2016-10-05       Impact factor: 9.261

8.  Relationship Between Estrogen Treatment and Skeletal Health in Women With Cystic Fibrosis.

Authors:  Malinda Wu; Erika L Bettermann; Neha Arora; William R Hunt; Courtney McCracken; Vin Tangpricha
Journal:  Am J Med Sci       Date:  2020-06-06       Impact factor: 2.378

9.  Young adults with cystic fibrosis have altered trabecular microstructure by ITS-based morphological analysis.

Authors:  M S Putman; L B Greenblatt; L Sicilian; A Uluer; A Lapey; G Sawicki; C M Gordon; M L Bouxsein; J S Finkelstein
Journal:  Osteoporos Int       Date:  2016-03-07       Impact factor: 4.507

Review 10.  Endocrine Disorders in Cystic Fibrosis.

Authors:  Scott M Blackman; Vin Tangpricha
Journal:  Pediatr Clin North Am       Date:  2016-08       Impact factor: 3.278

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.